Search Results Search Sort by RelevanceMost Recent History of Medicine Dec 2021 Living Histories of Structural Racism and Organized Medicine Robert Baker, PhD and Matthew K. Wynia, MD, MPH Mistakes and lessons from AMA history situate the AMA now for antiracist leadership in the health care sector. AMA J Ethics. 2021;23(12):E995-1003. doi: 10.1001/amajethics.2021.995. Case and Commentary Dec 2020 How Should Clinicians Respond When Patients’ Loved Ones Do Not See “Brain Death” as Death? Rabbi Jason Weiner, DBioethics and Rabbi Charles Sheer, MA, BCC Religious and cultural values can conflict with clinical standard practice and law. AMA J Ethics. 2020;22(12):E995-1003. doi: 10.1001/amajethics.2020.995. Podcast Dec 2021 Author Interview: “Living Histories of Structural Racism and Organized Medicine” Dr Matthew K. Wynia joins Ethics Talk to discuss his article, coauthored with Dr Robert Baker: “Living Histories of Structural Racism and Organized Medicine” AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Dec 2007 Communicable Disease and Immigration Fears Sonal S. Munsiff, MD Virtual Mentor. 2007;9(12):799-805. doi: 10.1001/virtualmentor.2007.9.12.ccas3-0712. In the Literature Dec 2007 Convincing Physicians to Report Communicable Diseases Sarah Lusk Virtual Mentor. 2007;9(12):811-813. doi: 10.1001/virtualmentor.2007.9.12.jdsc1-0712. State of the Art and Science Dec 2007 Diagnosing and Managing Pulmonary Tuberculosis David Pitrak, MD Virtual Mentor. 2007;9(12):814-818. doi: 10.1001/virtualmentor.2007.9.12.cprl1-0712. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
History of Medicine Dec 2021 Living Histories of Structural Racism and Organized Medicine Robert Baker, PhD and Matthew K. Wynia, MD, MPH Mistakes and lessons from AMA history situate the AMA now for antiracist leadership in the health care sector. AMA J Ethics. 2021;23(12):E995-1003. doi: 10.1001/amajethics.2021.995.
Case and Commentary Dec 2020 How Should Clinicians Respond When Patients’ Loved Ones Do Not See “Brain Death” as Death? Rabbi Jason Weiner, DBioethics and Rabbi Charles Sheer, MA, BCC Religious and cultural values can conflict with clinical standard practice and law. AMA J Ethics. 2020;22(12):E995-1003. doi: 10.1001/amajethics.2020.995.
Podcast Dec 2021 Author Interview: “Living Histories of Structural Racism and Organized Medicine” Dr Matthew K. Wynia joins Ethics Talk to discuss his article, coauthored with Dr Robert Baker: “Living Histories of Structural Racism and Organized Medicine”
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Dec 2007 Communicable Disease and Immigration Fears Sonal S. Munsiff, MD Virtual Mentor. 2007;9(12):799-805. doi: 10.1001/virtualmentor.2007.9.12.ccas3-0712.
In the Literature Dec 2007 Convincing Physicians to Report Communicable Diseases Sarah Lusk Virtual Mentor. 2007;9(12):811-813. doi: 10.1001/virtualmentor.2007.9.12.jdsc1-0712.
State of the Art and Science Dec 2007 Diagnosing and Managing Pulmonary Tuberculosis David Pitrak, MD Virtual Mentor. 2007;9(12):814-818. doi: 10.1001/virtualmentor.2007.9.12.cprl1-0712.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.